Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Bristol Myers Squibb Company (BMY) had Normalized Pre-Tax Income of $9.33B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$48.19B |
|
$7.05B |
|
$13.94B |
|
$34.26B |
|
$38.87B |
|
$9.33B |
|
-- |
|
$9.33B |
|
|
Normalized Pre-Tax Income |
$9.33B |
$7.06B |
|
$7.06B |
|
$7.06B |
|
$7.06B |
|
$9.33B |
|
$13.34B |
|
2.03B |
|
2.04B |
|
$3.47 |
|
$3.46 |
|
| Balance Sheet Financials | |
$29.39B |
|
$7.54B |
|
$60.65B |
|
$90.04B |
|
$23.42B |
|
$42.85B |
|
$48.12B |
|
$71.53B |
|
$18.51B |
|
$-22.35B |
|
$18.51B |
|
2.01B |
|
| Cash Flow Statement Financials | |
$14.16B |
|
$-4.13B |
|
$-10.35B |
|
$10.35B |
|
$10.22B |
|
$-129.00M |
|
$553.00M |
|
$-5.04B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.70 |
|
2.44 |
|
71.08% |
|
19.36% |
|
19.36% |
|
27.68% |
|
19.36% |
|
14.64% |
|
$12.85B |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
5.18 |
|
4.22 |
|
86.44 |
|
38.13% |
|
-31.57% |
|
7.84% |
|
11.50% |
|
$9.19 |
|
$6.30 |
|
$6.94 |
|